| | Business Summary | | NMT
Medical,
Inc.
develops
and
markets
medical
devices
that
utilize
advanced
technologies
and
are
delivered
by
minimally
invasive
procedures.
The
Company's
products
are
designed
to
offer
alternative
approaches
to
existing
complex
treatments,
thereby
reducing
patient
trauma,
shortening
procedure,
hospitalization
and
recovery
times
and
lowering
overall
treatment
costs.
NMT's
cardiovascular
business
unit
provides
the
interventional
cardiologist,
interventional
radiologist
and
vascular
surgeon
with
proprietary
catheter-based
implant
technologies
that
minimize
the
risk
of
embolic
events.
The
cardiovascular
business
unit
also
serves
the
pediatric
interventional
cardiologist
with
a
broad
range
of
cardiac
septal
repair
implants
delivered
with
non-surgical
catheter
techniques.
NMT's
neurosciences
business
unit
serves
the
needs
of
neurosurgeons
with
a
range
of
implantable
and
single-use
products,
including
cerebral
spinal
fluid
shunts,
external
drainage
products
and
aneurysm
clips. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | NMT
Medical
designs,
develops,
and
markets
innovative
medical
devices
that
utilize
advanced
technologies
and
are
delivered
by
minimally
invasive
procedures.
For
the
six
months
ended
6/30/01,
revenues
rose
5%
to
$20.2
million.
Net
income
from
continuing
operations
totalled
$613
thousand
vs.
a
loss
of
$7.7
million.
Revenues
reflect
an
increase
in
CardioSEAL
Septal
Occluder
sales.
Earnings
also
reflect
the
absence
of
$7.1
million
in
asset
impairment
charges. | | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| John Ahern, 56
Chairman,
Pres, CEO | $108K | Richard Davis, 43
CFO,
VP | 190K | | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/n/nmti.gif)